Meds & supplements › Gatifloxacin
Medicine
ZYMAXID ® is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus mitis group *…
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
ZYMAXID ® is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
*Efficacy for these organisms were studied in fewer than 10 infections.
The following serious adverse reactions are described elsewhere in the labeling:
ZYMAXID ® is contraindicated in patients with a history of hypersensitivity to gatifloxacin, to other quinolones, or to any of the components in this medication.
sofidex [Internet]. Daloreum; c2026. Gatifloxacin; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/gatifloxacin
sofidex. (2026, August 2). Gatifloxacin. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/gatifloxacin
Gatifloxacin. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/gatifloxacin
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.